BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 1258562)

  • 1. [Abnormality in the behaviour of mice after an experimental encephalitis by yellow fever virus 17 D. Experiment model(author's transl)].
    Henneberg G; Haase J; Museteanu C; Zausch GT
    Zentralbl Bakteriol Orig A; 1976 Jan; 234(1):1-13. PubMed ID: 1258562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Decrease in efficiency after experimental virus encephalitis. Small scale experimental tests on mice and histologic evaluation (author's transl)].
    Welte M
    Zentralbl Bakteriol Orig A; 1976 Dec; 236(4):439-63. PubMed ID: 1015029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sulphated glycosaminoglycans as virus inhibitors. 3rd communication: therapy of viral diseases by means of glycoasaminoglycanpolysulphates. Establishment of fundamentals in experiments with laboratory animals (author's transl)].
    Muşeţeanu C; Voss H
    Zentralbl Bakteriol Orig A; 1975 May; 231(4):375-88. PubMed ID: 126622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A contribution to infection with yellow fever virus 17D in chick embryos (author's transl)].
    Tinnefeld L; Haase J; Museteanu C
    Zentralbl Bakteriol Orig A; 1977 Apr; 237(4):453-69. PubMed ID: 559399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sulphated glycosaminoglycans as virus inhibitors. 2nd communication: Inhibitory effect of glycosaminoglycanpolysulphates on yellow fever virus 17 D in animal experiments (author's transl)].
    Museteanu C; Voss H; Rossner R
    Zentralbl Bakteriol Orig A; 1975; 230(3):298-305. PubMed ID: 125022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lesions in the central nervous system of the mouse caused by yellow fever 17 D. An animal model of the histological evaluation of viral encephalitis (author's transl)].
    Rodloff AC
    Zentralbl Bakteriol A; 1981; 249(2):152-61. PubMed ID: 7269849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between decreased mental efficiency in mice and the presence of cerebral lesions after experimental encephalitis caused by yellow fever virus.
    Museteanu C; Welte M; Henneberg G; Haase J
    J Infect Dis; 1979 Mar; 139(3):320-3. PubMed ID: 571891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Brain involvement in viral diseases. II. Experimental encephalitis of mice after infection with yellow fever virus strain 17 D and other brain lesions--a comparative analysis].
    Muşeţeanu C; Ahlert M; Haase J; Voss H
    Zentralbl Bakteriol Orig A; 1972 Dec; 222(4):431-45. PubMed ID: 4145161
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term infection of a cell culture from newborn mouse brain with the FNV strain of yellow fever virus (author's transl)].
    Fleury H; Adam C; Heme G
    Ann Microbiol (Paris); 1977; 128B(4):541-5. PubMed ID: 565183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental Junin virus infection in the mouse: rototype of the disease].
    Giovanniello OA; Boxaca MC; Nota NR; Nejamkis MR
    Rev Asoc Argent Microbiol; 1975; 7(1):88-14. PubMed ID: 1208899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular detection of yellow fever virus in human sera and mice brains].
    Méndez JA; Rodríguez G; Bernal Mdel P; de Calvache D; Boshell J
    Biomedica; 2003 Jun; 23(2):232-8. PubMed ID: 12872563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An oral enteritis-vaccine composed of twelve heat-inactivated Enterobacteriaceae 3. Communication: studies on efficacy tests in mice protection tests (author's transl)].
    Raettig H
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):511-20. PubMed ID: 7036591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment and assessment of the mouse model for spinal cord injury].
    Lu M; Quan Z; Liu B; Jiang D; Ou Y; Zhao J
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Aug; 22(8):933-8. PubMed ID: 18773808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.
    Freire MS; Mann GF; Marchevsky RS; Yamamura AM; Almeida LF; Jabor AV; Malachias JM; Coutinho ES; Galler R
    Vaccine; 2005 Mar; 23(19):2501-12. PubMed ID: 15752837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.
    Ryman KD; Xie H; Ledger TN; Campbell GA; Barrett AD
    Virology; 1997 Apr; 230(2):376-80. PubMed ID: 9143294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alteration of clinical outcome and histopathology of yellow fever virus infection in a hamster model by previous infection with heterologous flaviviruses.
    Xiao SY; Guzman H; da Rosa AP; Zhu HB; Tesh RB
    Am J Trop Med Hyg; 2003 Jun; 68(6):695-703. PubMed ID: 12887029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.